業績

2023年

Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex. Nucleic Acid Res. 7602-7618. 2023. J. Katahira, Tomoko Kohda (6/10), T. Okamoto

2022年

A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison　with Onabotulinumtoxin A. Kaji R, Miyashiro A, Seto N, Fukumoto T, Takeuchi T, Miyamoto R, Kohda T, Izumi Y, Kozaki S. Toxins. 14, doi: 10.3390/toxins14110739. 2022

2021年

Clinical safety and tolerability of A2NTX, a novel low-molecular-weight neurotoxin derived from botulinum neurotoxin subtype A2 in comparison with subtype A1 toxins. Takeuchi T, Okuno T, Miyashita A, Kohda T, Miyamoto R, Kozaki S, Izumi Y, Kaji R. Toxins. 13doi: 10.3390/toxins13110824. 2021

The cytotoxicity and molecular mechanisms of the Clostridium perfringens NetB toxin. Islam AA, Nakatani M, Nakajima T, Kohda T, Mukamoto M. J Vet Med Sci. 83; 187-194. 2021

2020年 

Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells. Kohda T, Tsukamoto K, Torii Y, Kozaki S, Mukamoto M. Microbiol Immunol. 64; 502-511. 2020

Fully human monoclonal antibodies effectively neutralizing botulinum neurotoxin serotype B. Matsumura T, Amatsu S, Misaki R, Yutani M, Du A, Kohda T, Fujiyama K, Ikuta K, Fujinaga Y. Toxins. 12, 302; doi:10.3390/toxins12050302. 2020